FDA Adds Diabetes & Memory Loss Warnings To Statins

Widely used cholesterol-lowering statin drugs like Lipitor (atorvastatin), Crestor (rosuvastatin), Zocor (simvastatin), Simcor (simvastatin/niacin extended-release), Vytorin (simvastatin/ezetimibe) and many others will now have additional warnings on their packaging, according to an announcement from the Food & Drug Administration. [More]

Drug Companies Pushing Up Prices In Patent-Ending Panic

Drug Companies Pushing Up Prices In Patent-Ending Panic

Get it while you can, big drug companies! Pharmaceutical giants like Pfizer Inc, AstraZeneca and Bristol Meyers Squibb are feeling a little panicky as the deadlines loom on patents for some of their best-selling drugs, so what do they do? Up the prices now, before those pesky generic versions arrive to drive consumer costs down. [More]

38,000 More Smelly Bottles Of Lipitor Recalled

38,000 More Smelly Bottles Of Lipitor Recalled

Pfizer is recalling 38,000 more bottles of Lipitor because the bottles smell musty. [More]

191,000 Bottles Of Lipitor Recalled Because Of Musty Odor

191,000 Bottles Of Lipitor Recalled Because Of Musty Odor

Though Pfizer apparently initiated a recall of its popular cholesterol fighting drug Lipitor (aka Atorvastatin) in August, it only came to the public attention this week. Regardless, a total of 191,000 90-pill bottles of the drug have been recalled from pharmacies in the U.S. and Canada. [More]

New Lipitor Ads Mercifully Free Of Fake Doctors

New Lipitor Ads Mercifully Free Of Fake Doctors

Well, it seems that Pfizer is ready to move on from that embarrassing “Dr. Jarvik is not actually licensed to practice medicine” kerfuffle back in February. The company pulled its Lipitor spots after Congress became very interested in whether or not the ads were misleading the public into believing that Dr. Jarvik was qualified to offer medical advice — and that he was really rowing that boat. Now, theWall Street Journal has a tantalizing preview of the new “Dr. Jarvik Free” Lipitor ad. The spot features a regular person named John — a heart attack survivor who urges you to learn from his example and be more proactive about controlling your cholesterol (with Lipitor, damn it! Lipitor!).

Say Goodbye To Dr. Jarvik As He and His Stunt Double Row Into The Sunset

Say Goodbye To Dr. Jarvik As He and His Stunt Double Row Into The Sunset

Weary of all the “fake rowing” controversy, Pfizer has canned Dr. Robert Jarvik (the inventor of the Jarvik artificial heart) as a spokesperson for their blockbuster cholesterol drug, Lipitor.

Congress Asks Pfizer: Why Did You Have A Stunt Double Row For Dr. Jarvik ?

Congress Asks Pfizer: Why Did You Have A Stunt Double Row For Dr. Jarvik ?

Congress has been asking some tough questions while wearing their serious faces about why Dr. Robert Jarvik (inventor of the Jarvik artificial heart) is shilling Lipitor when he’s not actually licensed to practice medicine.

Congress Asks Pfizer: Why Is Dr. Jarvik Qualified To Pitch Lipitor?

Congress Asks Pfizer: Why Is Dr. Jarvik Qualified To Pitch Lipitor?

Dr. Robert Jarvik is the inventor of the Jarvik artificial heart, right? You know that because he’s the pitch-man for Lipitor, a heavily advertised cholesterol drug. Have you ever stopped to ask yourself why inventing an artificial heart qualifies the man to pitch a drug?

Zocor May Cause Sleep Problems In Patients

Zocor May Cause Sleep Problems In Patients

A new study from the University of California at San Diego School of Medicine suggests that simvastatin, also known as the cholesterol-lowering drug Zocor, may interfere with sleep patterns: “people who took the statin drug Zocor or simvastatin found they had significantly worse sleep quality compared with people who took Pravachol or pravastatin, another cholesterol-lowering drug.” Simvastatin is fat soluble, which means it can more easily penetrate cell membranes and mess with brain chemistry.

Pfizer Launches Campaign To Warn Users Away From Generic Competitor

Pfizer Launches Campaign To Warn Users Away From Generic Competitor

Pfizer is in panic mode about its rapid decline in Lipitor sales—in the last 18 months, it has dropped from 40% of the market for cholesterol-lowering drugs to 30%, and likely to drop further—so it’s launched a big media-blitz to convince people not to switch to simvastatin, the generic version of its name-brand competitor, Zocor. Zocor was more expensive than Lipitor, so Pfizer had nothing to worry about for years—but then Zocor lost its patent protection last year, and now doctors are switching patients from Lipitor over to Zocor’s generic twin to save money.